UK May house prices slip by the most since 2009Nationwide
Johnson Matthey up on report of medical device unit spinoff
Pennon down as FY earnings drop
AstraZeneca up as US approves cancer drug
Dr Martens warns of hit to profits, shares drop to FTMC bottom

June 1 Reuters UK39;s FTSE 100 index edged up on Thursday, tracking an improvement in global mood, while footwear maker Dr Martens logged its worst day in over four months after warning of lower earnings for the upcoming year.

The bluechip FTSE 100 was up 0.5 as investors were relieved that the U.S. debt ceiling bill successfully passed through the House of Representatives, while hopes of the Federal Reserve pausing rate hikes further soothed the mood.

The midcap FTSE 250, meanwhile, eked out a small 0.2 gain, weighed by a 11.3 drop in Dr Martens Plc as CEO Kenny Wilson said that the U.S. is expected to be toughest market for the firm this year.

American consumers are becoming cautious about spending big on items they might want but don39;t need, said Susannah Streeter, head of money and markets, Hargreaves Lansdown.

Dr. Martens has also been compounded with the operational difficulties at its Los Angeles distribution centre, and fixing it might be more expensive than first thought.

AstraZeneca Plc added 0.8 after a combination of its cancer drug Lynparza and abiraterone gained approval in the U.S. for the treatment of a type of prostate cancer.

The broader healthcare sector rose 0.7.

UK equities had a…